Safe Orthopaedics

View in Terminal

Loading quotes...

Forecast

There is no analyst data available for this company.

Discussions in the community

There is no discussion about this asset yet.

Start discussion

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Financials

In the last quarter, Safe Orthopaedics had revenue of €2.87M and net profit of €954K

(EUR)	December 2025	YoY
Revenue	2.87M	-
Gross profit	0	-
Net profit	954K	-
EBITDA	-6M	-

Fundamentals

Metric	Value
Market capitalization	€115.98K
Number of shares	181.22K
52-week high/low	€2.60 - €0.54
Dividends	No
Beta	-0.85
P/E ratio	-0.01
PEG ratio	0.00
P/B ratio	-0.01
P/S ratio	0.02

Company profile

Safe Orthopaedics SA, a medical technology company, develops and markets sterile implants and single-use instruments for the treatment of spinal fracture pathologies in France and internationally. The company offers SteriSpine PS, an all-round kit for the treatment of spinal fractures and degenerative pathologies; and SteriSpine VA, a product platform for ready to use Kyphoplasty and Cement systems. It also provides SteriSpine LC, a ready to use instrumentation for lumbar cage portfolio, including Cedar and Elm; and SteriSpine CC, a ready to use instrumentation for cervical cage, such as Walnut. The company was founded in 2010 and is headquartered in Éragny-sur-Oise, France.